The facelifted Alfa Romeo Giulia and Stelvio will be sold in Ti, Veloce, and Quadrifoglio guises car auto cars
shores later this month and both will initially be offered in Ti and Veloce guises. The refreshed Quadrifoglio versions will launch in the fourth quarter of the year.
Kicking off the Giulia range is the Ti, priced from AU$68,450 while the Stelvio Ti is available from AU$76,450 . Among the key features of both Ti models is a new textured grille, black mirror caps, 19-inch alloy wheels, tinted taillights, automatic full LED Matrix headlights, matte exhaust tips, and for the Stelvio, both a Q4 badge and a Vesuvio Grey body kit.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
2024 Ford Ranger Raptor, 2024 Alfa Romeo Tonale, 2024 Ford Expedition: The Week In ReverseThe 2024 Ford Ranger Raptor debuted, we drove the 2024 Alfa Romeo Tonale, and the 2024 Ford Expedition broke cover. It's the Week in Reverse, right here at Motor Authority. The U.S.-spec 2024 Ford Ranger lineup debuted and with it came North America's first Ranger Raptor. The baby Raptor will sport the same powertrain (albeit with a slightly different power...
Weiterlesen »
Alfa Romeo Considers Assembling EVs In America | CarscoopsFor the first time in its 113-year history, Alfa Romeo may operate an assembly plant in the U.S., but the plans aren't set in stone yet car auto cars
Weiterlesen »
Review: New Alfa Romeo Tonale Is Big On Style And Space, But Hybrid Needs Work | CarscoopsAlfa's baby SUV impresses with ride comfort and space, but mild-hybrid engine is a mixed bag
Weiterlesen »
The Alfa Romeo Tonale Makes Me Want MoreThe Alfa Romeo Tonale makes me want more.
Weiterlesen »
This SF ‘Romeo & Juliet’ has something new — a happy endingL. Peter Callender’s more upbeat adaptation of the Shakespeare classic is presented by African-American Shakespeare Company.
Weiterlesen »
FDA OKs New Drug for Fabry DiseasePegunigalsidase alfa (Elfabrio) is an intravenously administered enzyme replacement therapy to treat adults with confirmed Fabry disease.
Weiterlesen »